FI49512C - Menetelmä uusien terapeuttisesti aktiivisten s-triatsinyylipiperatsiin ijohdannaisten valmistamiseksi. - Google Patents
Menetelmä uusien terapeuttisesti aktiivisten s-triatsinyylipiperatsiin ijohdannaisten valmistamiseksi.Info
- Publication number
- FI49512C FI49512C FI692827A FI282769A FI49512C FI 49512 C FI49512 C FI 49512C FI 692827 A FI692827 A FI 692827A FI 282769 A FI282769 A FI 282769A FI 49512 C FI49512 C FI 49512C
- Authority
- FI
- Finland
- Prior art keywords
- triazinyl
- preparation
- therapeutically active
- piperazine derivatives
- novel therapeutically
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4680268 | 1968-10-02 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI49512B FI49512B (fi) | 1975-04-01 |
| FI49512C true FI49512C (fi) | 1975-07-10 |
Family
ID=10442653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI692827A FI49512C (fi) | 1968-10-02 | 1969-10-01 | Menetelmä uusien terapeuttisesti aktiivisten s-triatsinyylipiperatsiin ijohdannaisten valmistamiseksi. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US3647794A (fi) |
| AT (1) | AT291271B (fi) |
| BE (1) | BE739283A (fi) |
| BR (1) | BR6912898D0 (fi) |
| CH (1) | CH517754A (fi) |
| DK (1) | DK129656B (fi) |
| ES (1) | ES371943A1 (fi) |
| FI (1) | FI49512C (fi) |
| FR (1) | FR2019646B1 (fi) |
| GB (1) | GB1256513A (fi) |
| IE (1) | IE33821B1 (fi) |
| NL (1) | NL142681B (fi) |
| NO (1) | NO124996B (fi) |
| SE (1) | SE350498B (fi) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7103449A (fi) * | 1971-03-15 | 1972-09-19 | ||
| GR74944B (fi) * | 1980-07-02 | 1984-07-12 | Merck & Co Inc | |
| FR2488509A1 (fr) | 1980-08-18 | 1982-02-19 | Science Union & Cie | Nouvelles compositions pharmaceutiques contenant de l'almitrine |
| FR2521560A1 (fr) * | 1982-02-17 | 1983-08-19 | Adir | Nouveaux derives de piperazine et d'homopiperazine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant |
| FR2525597B1 (fr) * | 1982-04-21 | 1985-06-07 | Adir | Polymethylene diamines n,n'-substituees, leurs procedes de preparation et les compositions pharmaceutiques les renfermant |
| FR2544315B1 (fr) * | 1983-04-12 | 1985-07-05 | Adir | Polymethylene imines disubstituees, leurs procedes de preparation, et les compositions pharmaceutiques les renfermant |
| FR2667243B1 (fr) * | 1990-09-27 | 1994-11-04 | Adir | Utilisation de s derives de la triazine et de la pyrimidine pour l'obtention de medicaments reversant la resistance aux agents anticancereux et antimalariques. |
| HU214331B (hu) * | 1992-06-17 | 1998-03-02 | Gyógyszerkutató Intézet Kft. | Eljárás piperazin- és homopiperazinszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására |
| SG11202000331YA (en) | 2017-07-13 | 2020-02-27 | Michael David Forrest | Therapeutic modulators of the reverse mode of atp synthase |
| US20230142073A1 (en) | 2020-03-15 | 2023-05-11 | Michael David FORREST | Almitrine for treating the hypoxemia of a coronavirus infection |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB946309A (en) * | 1959-09-02 | 1964-01-08 | Upjohn Co | Therapeutic gastric anti-secretory composition |
| DE1620528A1 (de) * | 1965-12-31 | 1970-06-11 | Thomae Gmbh Dr K | Verfahren zur Herstellung von neuen basisch substituierten s-Triazinen |
-
1968
- 1968-10-02 GB GB4680268A patent/GB1256513A/en not_active Expired
-
1969
- 1969-09-12 AT AT867469A patent/AT291271B/de not_active IP Right Cessation
- 1969-09-22 FR FR696932118A patent/FR2019646B1/fr not_active Expired
- 1969-09-23 BE BE739283D patent/BE739283A/xx not_active IP Right Cessation
- 1969-09-26 ES ES371943A patent/ES371943A1/es not_active Expired
- 1969-09-26 CH CH1459569A patent/CH517754A/fr not_active IP Right Cessation
- 1969-09-26 US US861448A patent/US3647794A/en not_active Expired - Lifetime
- 1969-09-29 SE SE13373/69A patent/SE350498B/xx unknown
- 1969-09-29 IE IE1347/69A patent/IE33821B1/xx unknown
- 1969-09-30 NL NL696914749A patent/NL142681B/xx not_active IP Right Cessation
- 1969-10-01 NO NO3917/69A patent/NO124996B/no unknown
- 1969-10-01 DK DK522869AA patent/DK129656B/da not_active IP Right Cessation
- 1969-10-01 FI FI692827A patent/FI49512C/fi active
- 1969-10-01 BR BR212898/69A patent/BR6912898D0/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CH517754A (fr) | 1972-01-15 |
| FR2019646A1 (fi) | 1970-07-03 |
| DK129656B (da) | 1974-11-04 |
| FI49512B (fi) | 1975-04-01 |
| IE33821B1 (en) | 1974-11-13 |
| AT291271B (de) | 1971-07-12 |
| GB1256513A (fi) | 1971-12-08 |
| DK129656C (fi) | 1975-04-07 |
| NO124996B (fi) | 1972-07-03 |
| FR2019646B1 (fi) | 1973-08-10 |
| US3647794A (en) | 1972-03-07 |
| BE739283A (fi) | 1970-03-23 |
| IE33821L (en) | 1970-04-02 |
| NL142681B (nl) | 1974-07-15 |
| NL6914749A (fi) | 1970-04-06 |
| SE350498B (fi) | 1972-10-30 |
| DE1947332A1 (de) | 1970-04-09 |
| ES371943A1 (es) | 1971-11-16 |
| BR6912898D0 (pt) | 1973-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI48460C (fi) | Menetelmä farmakologisesti vaikuttavien uusien amino-dihalogeenifenyyl ietyyliamiinien valmistamiseksi. | |
| FI49035C (fi) | Menetelmä terapeuttisesti käytettävän 2-bromi-alfa-ergokryptiinin valm istamiseksi. | |
| FI52858C (fi) | Menetelmä terapeuttisesti aktiivisten 1-(beta-aryyli)etyyli-imidatsoli johdannaisten valmistamiseksi. | |
| FI48590C (fi) | Menetelmä terapeuttisesti käytettävien atsaspiroalkaanidioniyhdisteide n valmistamiseksi. | |
| FI52335C (fi) | Menetelmä terapeuttisesti vaikuttavien trisyklisten etyyliamiini-johda nnaisten valmistamiseksi. | |
| FI44619C (fi) | Menetelmä uusien terapeuttisesti aktiivisten substituoitujen fenyyliet ikkahappojen valmistamiseksi. | |
| FI49512C (fi) | Menetelmä uusien terapeuttisesti aktiivisten s-triatsinyylipiperatsiin ijohdannaisten valmistamiseksi. | |
| FI49290C (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten benseenijohdannaiste n valmistamiseksi. | |
| FI47365C (fi) | Menetelmä valmistaa uusia terapeuttisesti vaikuttavia indolijohdannais ia. | |
| FI50334C (fi) | Menetelmä 1-hydroksi-2pyridonien valmistamiseksi. | |
| FI45041C (fi) | Menetelmä terapeuttisesti käyttökelpoisten pyrroli-johdannaisten valmi stamiseksi. | |
| FI47575C (fi) | Analogiamenetelmä evomonosidi-johdannaisten valmistamiseksi. | |
| FI45551C (fi) | Menetelmä terapeuttisesti käytettävän dehydroepiandrosteroniönantaatin valmistamiseksi. | |
| FI50971C (fi) | Menetelmä farmakologisesti tehoikkaiden substituoitujen fenyylialkaani happojen valmistamiseksi. | |
| FI45045C (fi) | Menetelmä uusien terapeuttisesti vaikuttavien 5-nitro-2-furyyli-isoksa tsolijohdannaisten valmistamiseksi. | |
| FI52577C (fi) | Menetelmä terapeuttisesti käytettävien fenatsiinijohdannaisten valmist amiseksi. | |
| FI47763C (fi) | Menetelmä uusien neriifoliini-johdannaisten valmistamiseksi. | |
| FI47189C (fi) | Tapa valmistaa terapeuttisesti vaikuttavia d-lysergiinihappo-N-fenyyli piperatsideja. | |
| FI49417C (fi) | Menetelmä farmakologisesti aktiivisten 2,3-dihydro-bentsofuraani-2-kar bonihappojen valmistamiseksi. | |
| FI48576C (fi) | Menetelmä terapeuttisesti aktiivisten alfa-fluori-malonihappojohdannai sten valmistamiseksi. | |
| FI50875C (fi) | Menetelmä terapeuttisesti aktiivisten dihydro-2-aminoisokinoliinien va lmistamiseksi. | |
| FI48190C (fi) | Menetelmä terapeuttisesti aktiivisten 10alfa-metoksi-9,10-dihydroergol iinijohdannaisten valmistamiseksi | |
| FI51811C (fi) | Menetelmä uusien terapeuttisesti käytettävien 2-okso-7-bentsoyyli-2,3- dihydrobentsofurfaanijohdannaisten valmistamiseksi | |
| FI52088C (fi) | Menetelmä 3-(4-asyylioksialkyyli-1-piperatsinyyli)-karbonyylimetyyli-2 -bentsotiatsolinonijohdannaisten valmistamiseksi. | |
| FI49162C (fi) | Menetelmä terapeuttisesti käytettävien 3-indolyyli-alifaattinen-happo- johdannaisten valmistamiseksi. |